glp-1 agonists diabetes Receptor Agonists: A Game-Changer for Type 2 Classification of glucagon-like peptide-1 receptor

Triple-Hormone-Receptor agonist Retatrutide for Obesity - A phase 2 trial

Impaired insulin sensitivity promotes adipose tissue hydrolysis, increasing circulating FFAs, which accumulate in hepatocytes, leading to steatosis (the first hit) [41]

Cells (2022) 11(16):2587

Sanofi aims at making therapy outcomes more effective, while also expanding treatment accessibility through research and product development initiatives

In head-to-head clinical trials, the tirzepatide group often showed greater weight reduction and better blood sugar control compared to the semaglutide group at the doses studied

The retrieved data included study characteristics, characteristics of patients, interventions, and outcome measures, that included the hazard ratios (HR) and confidence intervals (CI) for cardiorenal outcomes